Market revenue in 2023 | USD 816.5 million |
Market revenue in 2030 | USD 1,874.8 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Sequencing & Data Analytics Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to metagenomics market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.51% in 2023. Horizon Databook has segmented the North America metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. dominated North America’s market due to its extensive genomics, oncology, and wholegenome sequencing research. Other factors attributed to the significant adoption of metagenomics technology in this country are sophisticated research & medical infrastructure, funding, skilled personnel, and companies pushing for better research methods to identify newer technologies for diagnosis & therapies.
The U.S. is witnessing rapid clinical developments in NGS methodologies for applications in oncology and infectious diseases. The presence of market leaders, such as Illumina, Roche, and Life Technologies, which are involved in developing rapid and high-throughput sequencing capabilities, has contributed to the country’s market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America metagenomics market , including forecasts for subscribers. This continent databook contains high-level insights into North America metagenomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account